Interim Results Of The Phase I/Ii Study Of The Ponatinib, Venetoclax And Dexamethasone For Patients With Relapsed Or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
BLOOD(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要